NeoGenomics, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
NeoGenomics, Inc. (NEO) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.77% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-02-18
- NeoGenomics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.77%.
- NeoGenomics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.08%.
- NeoGenomics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.12%.
- NeoGenomics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -2.91%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -0.77% 10-K · filed 2025-02-18 | |
| 2023-12-31 | -0.08% 10-K · filed 2025-02-18 | |
| 2022-12-31 | -0.12% 10-K · filed 2025-02-18 | |
| 2021-12-31 | -2.91% 10-K · filed 2024-02-20 | 0.16% 10-K · filed 2022-02-25 |
| 2020-12-31 | -0.26% 10-K · filed 2023-02-24 | -0.06% 10-K · filed 2021-02-25 |
| 2019-12-31 | -2.78% 10-K · filed 2022-02-25 | -8.32% 10-K · filed 2020-02-28 |
| 2018-12-31 | 0.66% 10-K · filed 2021-02-25 | -1.21% 10-K · filed 2019-02-26 |
| 2017-12-31 | -3.72% 10-K · filed 2020-02-28 | -0.02% 10-K · filed 2018-03-13 |
| 2016-12-31 | 0.73% 10-K · filed 2019-02-26 | |
| 2013-12-31 | 0.26% 10-K · filed 2016-04-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |